What is the appropriate workup for a patient with a resting tremor?

Workup for Resting Tremor

MRI brain without contrast is the optimal initial imaging modality for evaluating resting tremor, combined with I-123 ioflupane (DaTscan) SPECT/CT when differentiation between Parkinsonian syndromes and non-degenerative tremor (essential tremor, drug-induced) is needed 1.

Clinical Assessment Framework

When evaluating resting tremor, focus on these specific diagnostic features:

Key Clinical Characteristics to Document

• Tremor context: Resting tremor that improves with movement strongly suggests Parkinsonism 1, 2
• "Pill-rolling" quality: Asymmetric thumb-finger oscillation at rest is pathognomonic for Parkinson's disease 2
• Re-emergent tremor: Tremor that reappears after holding a posture (arms outstretched) indicates Parkinsonian etiology 2
• Associated motor signs: Specifically assess for bradykinesia and rigidity, which distinguish Parkinsonian syndromes from isolated tremor disorders 1

Critical Prodromal/Associated Features

Look for these non-motor symptoms that precede motor manifestations:

• REM sleep behavior disorder
• Constipation
• Hyposmia (reduced sense of smell)
• Autonomic dysfunction 2

Medication Review

Systematically review for tremor-inducing medications, as drug-induced tremor is a common and reversible cause 2.

Imaging Algorithm

First-Line: MRI Brain Without Contrast

MRI is superior to CT due to soft-tissue characterization and sensitivity to iron deposition 1. MRI serves multiple purposes:

• Excludes structural lesions: Rules out focal pathology, vascular disease, or regional atrophy suggesting alternative diagnoses 1
• Identifies atypical Parkinsonism patterns:
  • MSA shows putaminal atrophy and T2 hyperintensity
  • PSP demonstrates midbrain atrophy ("hummingbird sign")
  • CBD shows asymmetric cortical atrophy 1
• Advanced sequences: Susceptibility-weighted imaging may show loss of the "swallow tail" sign in the substantia nigra, though sensitivity/specificity remain unclear 1

Important caveat: MRI findings in idiopathic Parkinson's disease are typically normal early in disease, which is actually diagnostically useful 1.

Second-Line: I-123 Ioflupane SPECT/CT (DaTscan)

This is the critical differentiating test when clinical diagnosis is uncertain 1. Use DaTscan when:

• Distinguishing Parkinsonian syndromes (PD, MSA, PSP, CBD) from essential tremor or drug-induced tremor
• Clinical examination is equivocal
• Early disease when anatomic imaging appears normal

Key interpretation:

• Normal DaTscan essentially excludes Parkinsonian syndromes 1
• Abnormal scan shows decreased striatal uptake (putamen > caudate), confirming dopaminergic neuronal loss
• Cannot distinguish between different Parkinsonian syndromes (all show abnormality) 1

Limited or No Role Imaging

• CT head: Not preferred due to limited soft-tissue characterization; use only if MRI contraindicated 1
• FDG-PET/CT: Limited evidence; may help distinguish PSP from PD but not first-line 1
• Amyloid PET/CT: No role in Parkinsonian syndrome evaluation 1
• MR spectroscopy or fMRI: No supporting evidence 1

Common Diagnostic Pitfalls

1. Assuming all resting tremor is Parkinson's disease: Atypical Parkinsonisms (MSA, PSP, CBD) present with resting tremor plus additional features and have different prognoses 1

2. Ordering DaTscan without clinical assessment: DaTscan cannot distinguish between different Parkinsonian syndromes—clinical features and MRI patterns are essential for this differentiation 1

3. Missing medication-induced tremor: Always review medications before pursuing expensive imaging 2

4. Ignoring tremor variability: Parkinsonian tremor is highly context-dependent; assess during cognitive tasks, motor co-activation, and various postures to adequately characterize it 3

Diagnostic Sequence

1. Detailed clinical examination focusing on tremor characteristics, associated motor signs, and prodromal symptoms 2, 4
2. Medication review for reversible causes 2
3. MRI brain without contrast as initial imaging 1
4. I-123 ioflupane SPECT/CT if diagnosis remains uncertain after clinical assessment and MRI 1

The combination of clinical assessment by an experienced clinician plus MRI is sufficient for diagnosis in most cases; DaTscan is reserved for diagnostically challenging presentations 4.